DocSym
β
Searchsearch
Search
(D05.1) Intraductal carcinoma in situ
More details coming soon
420 275 in individuals diagnosis intraductal carcinoma in situ confirmed
4 007 deaths with diagnosis intraductal carcinoma in situ
1% mortality rate associated with the disease intraductal carcinoma in situ
Diagnosis intraductal carcinoma in situ is diagnosed Women are 99.28% more likely than Men
1 522
Men receive the diagnosis intraductal carcinoma in situ
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
418 753
Women receive the diagnosis intraductal carcinoma in situ
4 007 (1.0 %)Died from this diagnosis.
Risk Group for the Disease intraductal carcinoma in situ - Men aged 70-74 and Women aged 50-54
In Men diagnosis is most often set at age 40-49, 70-74, 85-89
Less common in men the disease occurs at Age 0-39, 50-69, 75-84, 90-95+Less common in women the disease occurs at Age 0-14, 95+
In Women diagnosis is most often set at age 0-1, 15-94
Disease Features intraductal carcinoma in situ
Absence or low individual and public risk
Intraductal carcinoma in situ - what does this mean
Intraductal carcinoma in situ (dcis) is a pre-invasive form of breast cancer where abnormal cells are found in the lining of the milk ducts of the breast, but have not spread to the surrounding tissue. it is usually detected by a mammogram, but may also be found during a biopsy. dcis is considered a non-invasive form of breast cancer, but if left untreated, it can lead to invasive breast cancer.
What happens during the disease - intraductal carcinoma in situ
Intraductal carcinoma in situ is a pre-invasive form of breast cancer in which abnormal cells are present within the lining of the breast ducts but have not spread beyond them. it is believed to arise due to a combination of genetic and environmental factors, such as a family history of breast cancer, exposure to certain hormones, and certain lifestyle factors. this can cause the cells to become abnormal and grow out of control, forming a mass within the ducts. in some cases, this can lead to the development of invasive breast cancer.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Mammogram
- Ultrasound
- Biopsy
- MRI
- CT Scan
- PET Scan
- Blood Test
Treatment and Medical Assistance
Main goal of the treatment: To reduce the risk of cancer progressing to invasive cancer.
- Surveillance including regular mammograms and clinical breast exams.
- Cryoablation, which involves freezing the abnormal cells.
- Radiofrequency ablation, which involves delivering a high frequency electrical current to the abnormal cells.
- Lumpectomy, which involves surgically removing the abnormal cells.
- Mastectomy, which involves surgically removing the entire breast.
- Hormone therapy, which involves taking medications to reduce the risk of cancer progression.
- Chemotherapy, which involves taking medications to kill cancer cells.
- Radiation therapy, which involves using high-energy radiation to kill cancer cells.
12 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Intraductal carcinoma in situ - Prevention
Intraductal carcinoma in situ can be prevented by maintaining a healthy lifestyle, including avoiding smoking, limiting alcohol consumption, eating a balanced diet, and exercising regularly. additionally, regular breast self-exams and mammograms can help detect any changes in the breast tissue that may indicate the presence of this disease.